Report to the Pharmaceutical Benefits Advisory Committee on the clinical and cost-effectiveness of the biological disease modifying anti-rheumatic drugs

PA Scuffham; P Whyte; JA Whitty; S-K Ng; V Priest; T Comans; E Turkstra

Report to the Pharmaceutical Benefits Advisory Committee on the clinical and cost-effectiveness of the biological disease modifying anti-rheumatic drugs

PA Scuffham, P Whyte, JA Whitty, S-K Ng, V Priest, T Comans, E Turkstra

Research output: Book/Report › Commissioned report

Original language	English
Publisher	Griffith University
Publication status	Published - Sept 2009

Cite this

@book{5cce5b9af8414bf2b4374b602531cee0,

title = "Report to the Pharmaceutical Benefits Advisory Committee on the clinical and cost-effectiveness of the biological disease modifying anti-rheumatic drugs",

author = "PA Scuffham and P Whyte and JA Whitty and S-K Ng and V Priest and T Comans and E Turkstra",

year = "2009",

month = sep,

language = "English",

publisher = "Griffith University",

}

TY - BOOK

T1 - Report to the Pharmaceutical Benefits Advisory Committee on the clinical and cost-effectiveness of the biological disease modifying anti-rheumatic drugs

AU - Scuffham, PA

AU - Whyte, P

AU - Whitty, JA

AU - Ng, S-K

AU - Priest, V

AU - Comans, T

AU - Turkstra, E

PY - 2009/9

Y1 - 2009/9

M3 - Commissioned report

BT - Report to the Pharmaceutical Benefits Advisory Committee on the clinical and cost-effectiveness of the biological disease modifying anti-rheumatic drugs

PB - Griffith University

ER -